. 2013 Oct 25;40(12):6899–6911. doi: 10.1007/s11033-013-2809-7

Table 8.

Selected combined effects of the IL-12A rs568408 and IL-12B rs3212227 polymorphisms in infected hemodialysis patients

Genotypes	Group IIa (n = 55) Frequency (%)	Group IIb (n = 182) Frequency (%)	OR (95 % CI)	P value
rs568408 GG and rs3212227 AA	24 (43.6)	74 (40.7)	Referent
rs568408 GG and rs3212227 AC	7 (12.7)	53 (29.1)	4.6 (1.3–16.5)^a	0.019^c
rs568408 GG and rs3212227 AC	7 (12.7)	53 (29.1)	Referent
rs568408 GG and rs3212227 CC	4 (7.3)	3 (1.6)	0.06 (0.008–0.4)^a	0.005^b
rs568408 AA and rs3212227 AA	2 (3.6)	1 (0.5)	0.5 (0.3–0.8)^a	0.009^c

^aOdds ratio (OR) after adjustment for HBV surface antigen and chronic glomerulonephritis as a cause of renal replacement therapy

^bSignificant after the Bonferroni correction for multiple comparisons (P < 0.006)

^cNon-significant after the Bonferroni correction for multiple comparisons (P > 0.006)